REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,474,622 | -26.3% | 612,193 | 0.0% | 0.07% | -28.2% |
| Q2 2023 | $14,215,122 | +31.9% | 612,193 | -7.7% | 0.10% | +37.3% |
| Q1 2023 | $10,775,714 | -40.2% | 662,922 | 0.0% | 0.08% | -38.5% |
| Q4 2022 | $18,030,633 | +71.3% | 662,922 | +8.8% | 0.12% | +64.9% |
| Q3 2022 | $10,528,000 | +22.3% | 609,572 | +23.8% | 0.07% | +4.2% |
| Q2 2022 | $8,609,000 | +2.9% | 492,504 | 0.0% | 0.07% | +24.6% |
| Q1 2022 | $8,363,000 | -40.6% | 492,504 | -5.2% | 0.06% | -36.7% |
| Q4 2021 | $14,079,000 | -9.0% | 519,512 | -0.5% | 0.09% | -14.3% |
| Q3 2021 | $15,476,000 | -17.1% | 522,141 | +7.4% | 0.10% | -18.0% |
| Q2 2021 | $18,671,000 | +214.2% | 485,988 | +199.7% | 0.13% | +161.2% |
| Q1 2021 | $5,943,000 | -3.9% | 162,160 | +0.0% | 0.05% | 0.0% |
| Q4 2020 | $6,186,000 | – | 162,154 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |